Patents by Inventor Gerard F. Barry
Gerard F. Barry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20090240073Abstract: The invention relates in general to methods for detoxifying phosphonate herbicides. The methods may comprise transacetylating the phosphonate herbicide. The phosphonate herbicides can comprise a CP bond and a CN bond and may be glyphosate.Type: ApplicationFiled: March 11, 2008Publication date: September 24, 2009Inventor: Gerard F. Barry
-
Patent number: 7554012Abstract: The invention relates in general to plants, plant cells, methods of making, and methods of using plants and plant cells transformed to express an acetyltransferase that transfers an acyl group to the terminal amine of AMPA, and to plants and plant cells exhibiting resistance to AMPA in an amount which inhibits the growth of a plant or plant cell lacking a sequence encoding the acetyltransferase.Type: GrantFiled: August 7, 2002Date of Patent: June 30, 2009Assignee: Monsanto Technology LLCInventor: Gerard F. Barry
-
Publication number: 20040073976Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.Type: ApplicationFiled: November 11, 2003Publication date: April 15, 2004Applicant: Monsanto Technology LLCInventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
-
Patent number: 6716474Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.Type: GrantFiled: August 6, 2001Date of Patent: April 6, 2004Assignee: Monsanto Technology LLCInventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
-
Patent number: 6663906Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.Type: GrantFiled: June 6, 2002Date of Patent: December 16, 2003Assignee: Monsanto Technology LLCInventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
-
Publication number: 20030126641Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.Type: ApplicationFiled: June 6, 2002Publication date: July 3, 2003Applicant: Monsanto Technology LLCInventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
-
Publication number: 20030106096Abstract: The invention relates in general to herbicide resistance in plants, and more particularly to a new class of phosphonate metabolizing genes, and methods of using these genes for improving plant tolerance to phosphonate herbicides.Type: ApplicationFiled: August 7, 2002Publication date: June 5, 2003Inventor: Gerard F. Barry
-
Publication number: 20020138875Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.Type: ApplicationFiled: August 6, 2001Publication date: September 26, 2002Applicant: Monsanto Technology, LLC.Inventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
-
Patent number: 6448476Abstract: The invention relates in general to plants, plant cells, methods of making, and methods of using plants and plant cells transformed to contain a DNA sequence encoding an AMPA-N-acetyltransferase, and to plants and plant cells exhibiting resistance to AMPA in an amount which inhibits the growth of a plant or plant cell lacking a sequence encoding an AMPA-N-acetyltransferase.Type: GrantFiled: November 16, 1999Date of Patent: September 10, 2002Assignee: Monsanto Technology LLCInventor: Gerard F. Barry
-
Patent number: 6441277Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.Type: GrantFiled: June 16, 1998Date of Patent: August 27, 2002Assignee: Monsanto Technology LLCInventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
-
Patent number: 5633435Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.Type: GrantFiled: September 13, 1994Date of Patent: May 27, 1997Assignee: Monsanto CompanyInventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings
-
Patent number: 5627061Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.Type: GrantFiled: June 7, 1995Date of Patent: May 6, 1997Assignee: Monsanto CompanyInventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings
-
Patent number: 5608149Abstract: Promoters for enhanced expression of ADPglucose pyrophosphorylase in potato tubers and fruits such as tomato; methods of using them; DNA molecules, plant cells and plants containing them. A method of decreasing the oil content of seeds by expression of ADPglucose pyrophosphorylase.Type: GrantFiled: March 3, 1995Date of Patent: March 4, 1997Assignee: Monsanto CompanyInventors: Gerard F. Barry, Ganesh M. Kishore, David M. Stark
-
Patent number: 5536653Abstract: Promoters isolated from potato which cause expression of a gene of choice in tomato; tomato plant cells and plants containing them.Type: GrantFiled: November 4, 1994Date of Patent: July 16, 1996Assignee: Monsanto CompanyInventors: Gerard F. Barry, Janice W. Edwards, Ganesh M. Kishore, David M. Stark
-
Patent number: 5498830Abstract: Promoters for enhanced expression of ADPglucose pyrophosphorylase in potato tubers and fruits such as tomato; methods of using them; DNA molecules, plant cells and plants containing them. A method of decreasing the oil content of seeds by expression of ADPglucose pyrophosphorylase.Type: GrantFiled: July 12, 1993Date of Patent: March 12, 1996Assignee: Monsanto CompanyInventors: Gerard F. Barry, Ganesh M. Kishore, David M. Stark
-
Patent number: 5463175Abstract: Genes encoding a glyphosate oxidoreductase enzyme are disclosed. The genes are useful in producing transformed bacteria and plants which degrade glyphosate herbicide as well as crop plants which are tolerant to glyphosate herbicide.Type: GrantFiled: February 21, 1995Date of Patent: October 31, 1995Assignee: Monsanto CompanyInventors: Gerard F. Barry, Ganesh M. Kishore
-
Patent number: RE38825Abstract: Genes encoding a glyphosate oxidoreductase enzyme are disclosed. The genes are useful in producing transformed bacteria and plants which degrade glyphosate herbicide as well as crop plants which are tolerant to glyphosate herbicide.Type: GrantFiled: July 7, 2000Date of Patent: October 11, 2005Assignee: Monsanto Technology LLCInventors: Gerard F. Barry, Ganesh M. Kishore
-
Patent number: RE39247Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.Type: GrantFiled: July 18, 2003Date of Patent: August 22, 2006Assignee: Monsanto Technology LLCInventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings